Dr. Gavin E. Reid is the Professor of Bioanalytical Chemistry in the School of Chemistry and the Department of Biochemistry and Molecular Biology, and member of the multidisciplinary Bio21 Molecular Science and Biotechnology Institute, at The University of Melbourne, Australia. Over the past 30 years, he has held a variety of technical research positions and academic appointments in Australia and the USA, including at the Ludwig Institute for Cancer Research in Melbourne (1987−1997 and 2002− 2004) and at Michigan State University, MI, USA (2004−2014). Research in the Reid laboratory is broadly directed toward the development of analytical biochemistry, mass spectrometry, and associated chemical strategies for quantitative proteome and lipidome analysis, and their application toward identifying the functional role of proteins and lipids in the regulation of cellular function, and in the onset and progression of disease, including cancer. To date, this inter-disciplinary and highly collaborative research has resulted in >150 peer-reviewed publications, >150 conference and invited seminar presentations, and 4 patents, with funding received from the National Institutes of Health, the National Science Foundation, the National Health and Medical Research Council, the Australian Research Council, the Multiple Myeloma Research Foundation, the Juvenile Diabetes Research Foundation, the Centers for Disease Control, and multiple philanthropic, government and industry groups. Gavin served from 2012-2014 on the Board of Directors of the American Society for Mass Spectrometry, and was Treasurer of the Australasian Proteomics Society from 2015-2017. He is currently President of the Australian and New Zealand Society for Mass Spectrometry, an Associate Editor for the Journal of the American Society for Mass Spectrometry, and is on the Editorial Advisory Boards for the Journal of Mass Spectrometry, the Journal of Lipid Research, and the European Journal of Mass Spectrometry.